FDA-Inspected Site

University of Texas MD Anderson Cancer Center

5 FDA inspections are on record for University of Texas MD Anderson Cancer Center in Houston, United States.

Clean· No action indicated

Houston, United States · Last updated July 10, 2026

Overview

  • 5 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-02-20.

At a glance

Inspections

5

Form 483s

2

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
18 Feb 2026 – 20 Feb 2026BiologicsClean
10 Sep 2024 – 16 Sep 2024BiologicsClean
16 Mar 2022 – 24 Mar 2022Biologics483View 483 →
9 Dec 2019 – 12 Dec 2019BiologicsClean
26 Feb 2018 – 2 Mar 2018Biologics483On file

Observations on record

Form 483 observations cited at this site, most recent first.

24 Mar 2022
21 CFR 211.115(a)

Reprocessing procedures not written or followed

Cited by Darla J Christopher, Lauren M Lilly

24 Mar 2022
21 CFR 211.115(a)

Reprocessing procedures not written or followed

Cited by Darla J Christopher, Lauren M Lilly

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.115(a)Cited across public-safe Form 483 observations2x

Full site report

Get the verbatim findings behind University of Texas MD Anderson Cancer Center's 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat